Neutrophil Elastase Contributes to the Early Diabetic Retinopathy

Neutrophil Elastase Contributes to the Early Diabetic Retinopathy

Posted by Corey Marcath on

Mouse Alpha 1 Antitrypsin (A1AT) ELISA Kit from Innovative Research was used in the following study:

 

Neutrophil Elastase Contributes to the Early Diabetic Retinopathy

Haitao Liu

Case Western Reserve University, Department of Biology
May 2019

“…It is well documented that oxidative stress and inflammation are involved in the degeneration of retinal capillaries in diabetes, a hallmark of diabetic retinopathy (DR), and it has been shown that leukocytes, especially neutrophils, play a causal role in retinal abnormalities including diabetic-induced degeneration of retinal capillaries observed in DR. …Mouse alpha-1 antitrypsin ELISA kit (Innovative Research, Novi, MI, IRKTAH1147) was used for detecting and quantifying mouse AAT in the circulating plasma…”

 

Related products available from Innovative Research also include:

  • Tags: ELISA Kit

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
    In the ever-evolving landscape of molecular biology, precision tools are essential for ...
    Read the Article
    Revolutionizing Diabetes Treatment: Genetically Engineered Pseudo-Islets Achieve Insulin Independence
    In a groundbreaking study, researchers have pioneered a diabetes treatment that could r...
    Read the Article
    Pioneering Advances in Complement-Mediated Disorders: An In-depth Look at SAR443809
    In the dynamic landscape of medical research, SAR443809 emerges as a promising candidat...
    Read the Article

    ← Older Post Newer Post →

    ×